Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis - DiSantostefano, R L; Li, H; Hinds, D (Int J Chron Obstruct Pulmon Dis, 2014)
et al.